| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 3.4K | 1.2% | 4.8% |
| Total Income | 3.4K | 1.2% | 4.8% |
| Expenditure | 2.9K | 2.6% | 6.8% |
| PBT | 308.80 | 16.3% | 17.3% |
| Net Profit | 150.33 | 24.6% | 30.0% |
| OPM | 14.79% | 1.13pp | 1.60pp |
| NPM | 4.39% | 1.50pp | 2.18pp |
| EPS | 2.09 | 20.2% | 18.4% |
DaVita Inc. Reports Q3 2025 Results: Revenue $3.42 Billion
04 May 2026 · 4 May, 8:35 am
Summary
DaVita Inc. announced its financial and operating results for the quarter ended September 30, 2025. Consolidated revenues for the quarter were $3.420 billion. Operating income was reported at $506 million, with an adjusted operating income of $517 million. Diluted earnings per share stood at $2.04, and adjusted diluted earnings per share was $2.51. The company also refinanced its Term Loan B-1 and repurchased 3.3 million shares of its common stock.
Key Highlights
- 1
DaVita's consolidated revenues for the third quarter of 2025 were $3.420 billion.
- 2
Operating income for Q3 2025 was $506 million, while adjusted operating income reached $517 million.
- 3
Diluted earnings per share for the third quarter of 2025 was $2.04, and adjusted diluted earnings per share was $2.51.
- 4
Operating cash flow for the third quarter of 2025 amounted to $842 million, with free cash flow at $604 million.
- 5
The company refinanced its existing Term Loan B-1 with a new $1.9 billion Term Loan B-2.
- 6
DaVita repurchased 3.3 million shares of its common stock at an average price of $140.67 per share during the quarter.
- 7
Total U.S. dialysis treatments for the third quarter of 2025 were 7,242,725, averaging 91,680 treatments per day.
Management Comments
Javier Rodriguez
“Our third quarter performance was in line with our expectations and keeps us on track to achieve our full-year guidance. Our consistent focus on providing outstanding care is the key to these results, enabling us to continuously invest in improving the lives of our patients and supporting our dedicated teammates and physician partners.”
Informational and educational content only. Not investment advice.